Rebecca Persson

627 total citations
30 papers, 434 citations indexed

About

Rebecca Persson is a scholar working on Rheumatology, Oncology and Health Information Management. According to data from OpenAlex, Rebecca Persson has authored 30 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Oncology and 5 papers in Health Information Management. Recurrent topics in Rebecca Persson's work include Rheumatoid Arthritis Research and Therapies (8 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Multiple Sclerosis Research Studies (4 papers). Rebecca Persson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Multiple Sclerosis Research Studies (4 papers). Rebecca Persson collaborates with scholars based in United States, United Kingdom and Canada. Rebecca Persson's co-authors include Susan S. Jick, Katrina Wilcox Hagberg, Catherine Vasilakis‐Scaramozza, Steve J. Niemcryk, Neil Minton, Marianne Ulcickas Yood, Puja Myles, Amber Evans, Ann C. Garlitski and Ethan M. Balk and has published in prestigious journals such as Annals of Internal Medicine, Neurology and BMJ.

In The Last Decade

Rebecca Persson

28 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Persson United States 14 106 82 67 57 49 30 434
Jingbo Zhao China 12 41 0.4× 72 0.9× 23 0.3× 21 0.4× 37 0.8× 46 560
Alexandr Ceasovschih Romania 12 25 0.2× 87 1.1× 20 0.3× 27 0.5× 64 1.3× 56 337
Ehizogie Edigin United States 11 25 0.2× 42 0.5× 84 1.3× 32 0.6× 21 0.4× 72 344
David Metz United States 11 17 0.2× 37 0.5× 98 1.5× 43 0.8× 25 0.5× 19 360
Bili Zhang China 11 24 0.2× 86 1.0× 16 0.2× 42 0.7× 116 2.4× 45 486
Brian C. Boursiquot United States 9 32 0.3× 65 0.8× 13 0.2× 43 0.8× 146 3.0× 13 500
Harry Steinberg United States 15 145 1.4× 61 0.7× 13 0.2× 45 0.8× 38 0.8× 34 615
C. Kempf France 9 16 0.2× 46 0.6× 20 0.3× 18 0.3× 37 0.8× 21 318
Melda Dilek Türkiye 12 17 0.2× 97 1.2× 56 0.8× 24 0.4× 49 1.0× 32 457

Countries citing papers authored by Rebecca Persson

Since Specialization
Citations

This map shows the geographic impact of Rebecca Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Persson more than expected).

Fields of papers citing papers by Rebecca Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Persson. The network helps show where Rebecca Persson may publish in the future.

Co-authorship network of co-authors of Rebecca Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Persson. A scholar is included among the top collaborators of Rebecca Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Persson. Rebecca Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasilakis‐Scaramozza, Catherine, Rebecca Persson, George Kafatos, et al.. (2025). Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother‐Baby Link. Pharmacoepidemiology and Drug Safety. 34(2). e5860–e5860. 1 indexed citations
2.
Persson, Rebecca, et al.. (2024). Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink. Osteoporosis International. 36(1). 47–60. 1 indexed citations
3.
Hagberg, Katrina Wilcox, Catherine Vasilakis‐Scaramozza, Rebecca Persson, et al.. (2023). Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2). Clinical Epidemiology. Volume 15. 1193–1206. 4 indexed citations
4.
Vasilakis‐Scaramozza, Catherine, Katrina Wilcox Hagberg, Rebecca Persson, et al.. (2023). Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3). Clinical Epidemiology. Volume 15. 1207–1218. 1 indexed citations
5.
Hagberg, Katrina Wilcox, Catherine Vasilakis‐Scaramozza, Rebecca Persson, et al.. (2023). Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1). Clinical Epidemiology. Volume 15. 1183–1192. 5 indexed citations
6.
Jick, Susan S., Catherine Vasilakis‐Scaramozza, Rebecca Persson, et al.. (2023). Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments. Clinical Epidemiology. Volume 15. 1219–1222. 10 indexed citations
7.
Persson, Rebecca, Katrina Wilcox Hagberg, Catherine Vasilakis‐Scaramozza, et al.. (2022). Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. Clinical Epidemiology. Volume 14. 641–652. 4 indexed citations
8.
Vasilakis‐Scaramozza, Catherine, Katrina Wilcox Hagberg, Rebecca Persson, et al.. (2022). Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum. Pharmacoepidemiology and Drug Safety. 32(1). 73–77. 5 indexed citations
9.
Persson, Rebecca, Myriam Cordey, Maria Paris, & Susan S. Jick. (2022). Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink. Drug Safety. 45(11). 1403–1411. 7 indexed citations
10.
Persson, Rebecca, Todd R. Sponholtz, Catherine Vasilakis‐Scaramozza, et al.. (2021). Quality and Completeness of Myocardial Infarction Recording in Clinical Practice Research Datalink Aurum. Clinical Epidemiology. Volume 13. 745–753. 14 indexed citations
11.
Persson, Rebecca, et al.. (2020). The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids. Lara D. Veeken. 60(4). 1926–1931. 22 indexed citations
12.
Persson, Rebecca, Marianne Ulcickas Yood, Neil Minton, et al.. (2020). Infections in patients diagnosed with multiple sclerosis: A multi-database study. Multiple Sclerosis and Related Disorders. 41. 101982–101982. 69 indexed citations
13.
Persson, Rebecca, Marianne Ulcickas Yood, Michael Wagner, et al.. (2020). Incident depression in patients diagnosed with multiple sclerosis: a multi‐database study. European Journal of Neurology. 27(8). 1556–1560. 8 indexed citations
14.
Persson, Rebecca, Catherine Vasilakis‐Scaramozza, Katrina Wilcox Hagberg, et al.. (2020). CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiology and Drug Safety. 29(11). 1456–1464. 34 indexed citations
15.
Hagberg, Katrina Wilcox, Rebecca Persson, Catherine Vasilakis‐Scaramozza, et al.. (2020). <p>Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis</p>. Clinical Epidemiology. Volume 12. 153–161. 22 indexed citations
16.
Persson, Rebecca, Sally Lee, Marianne Ulcickas Yood, et al.. (2019). Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries. Journal of Neurology. 266(5). 1095–1106. 15 indexed citations
17.
Persson, Rebecca, Sally Lee, Marianne Ulcickas Yood, et al.. (2019). Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study. Multiple Sclerosis and Related Disorders. 37. 101423–101423. 31 indexed citations
18.
Hagberg, Katrina Wilcox, Hozefa A. Divan, Rebecca Persson, J. Curtis Nickel, & Susan S. Jick. (2016). Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. BMJ. 354. i4823–i4823. 23 indexed citations
19.
Earley, Amy, Rebecca Persson, Ann C. Garlitski, Ethan M. Balk, & Katrin Uhlig. (2014). Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in Subgroups. Annals of Internal Medicine. 160(2). 111–121. 27 indexed citations
20.
Persson, Rebecca, Amy Earley, Ann C. Garlitski, Ethan M. Balk, & Katrin Uhlig. (2014). Adverse events following implantable cardioverter defibrillator implantation: a systematic review. Journal of Interventional Cardiac Electrophysiology. 40(2). 191–205. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026